Unveiling esophageal cancer treatment mechanisms: network pharmacology and molecular docking of Physcion

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Esophageal cancer remains a significant health challenge with limited effective treatments.
• Identifying novel therapeutic agents and understanding their mechanisms of action are crucial for improving patient outcomes.

Purpose of the Study:

• To investigate the therapeutic effects of Physcion on esophageal cancer.
• To elucidate the underlying molecular mechanisms and identify potential drug targets.
• To assess the diagnostic potential of key genes and Physcion's binding affinity to them.

Main Methods:

• Bioinformatic analysis of transcriptomic data from esophageal cancer tissues.
• Identification and validation of key differentially expressed genes.
• Pathway enrichment analysis (KEGG) and molecular docking simulations.
• In vitro assays to evaluate Physcion's effects on esophageal cancer cells.

Main Results:

• 16 pivotal genes were identified, with significant involvement in the PI3K/AKT pathway.
• Physcion exhibited strong binding affinity to Heat Shock Protein 90 Alpha Class A Member 1 (HSP90AA1) and Matrix Metallopeptidase 2 (MMP2).
• In vitro studies confirmed Physcion's dose- and time-dependent inhibitory effects on esophageal cancer cells.

Conclusions:

• Physcion shows significant promise as a therapeutic agent for esophageal cancer.
• The study provides a foundation for the clinical development of Physcion.
• Further research into Physcion's mechanisms and clinical efficacy is warranted.